Elevance Health Inc

ELV: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|@mLOCK|>#q>bLOCK|@Y&TZ<>

Elevance Earnings: Management Sticks to 2025 Guidance but Foreshadows Weak 2026 in Medicaid

Elevance Health's third-quarter results included low-double-digit revenue growth and a 30% decline in adjusted earnings per share. Despite the lower profits, the company is tracking toward management's 2025 guidance, which includes a roughly 10% decline in adjusted EPS.

Sponsor Center